Australia
Enfinity Global & ICG complete €400 million equity agreement
MIAMI, Oct. 25, 2023 /PRNewswire/ -- Enfinity Global, a leader in renewable energy, today announced the successful completion of €300 million equity funding from ICG, the global alternative asset manager. Another €100 million of equity funding is expected to close within a one-year period as part...
2023-10-25 21:32
2566
Xailient and Morse Micro Join Forces to Transform the Future of Smart Cameras
Wi-Fi HaLow™ Technology Enables Long-Range, Low-Power Connectivity for Smart Cameras SYDNEY and IRVINE, Calif., Oct. 25, 2023 /PRNewswire/ -- Xailient, the leader in edge artificial intelligence (AI) for computer vision, today announced a strategic partnership with Morse Micro, a fast-growing fa...
2023-10-25 21:05
2280
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis
MELBOURNE, Australia, Oct. 23, 2023 /PRNewswire/ -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ...
2023-10-23 21:30
1833
Actinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Boston
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsychiatric diseases SYDNEY, Oct. 13, 2023 /PRNewswire/ -- Acti...
2023-10-13 20:00
2936
AACR OVARIAN CANCER CONFERENCE PRESENTATION
HIGHLIGHTS * Data from preclinical studies in ovarian cancer presented at premier international conference inBoston, USA. * Results indicate that Amplia's proprietary FAK inhibitor narmafotinib (AMP945) performs better than standard-of-care in models of chemotherapy-resistant high-grade ser...
2023-10-09 15:18
1817
First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
SYDNEY, Oct. 3, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the dosing of the first ...
2023-10-03 20:58
2491
FlexRule's Decision-Centric Approach® methodology empowers organizations to make quality decisions, fast
MELBOURNE, Australia, Sept. 28, 2023 /PRNewswire/ -- FlexRule®, a leading Decision Management Suite, is proud to announce that its Decision-Centric Approach® has been officially trademarked. The Decision-Centric Approach® is a methodology that brings people, rules, data, and processes together...
2023-09-28 12:32
2015
Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business update
Highlights Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design and trial endpoints. UK sites added to the XanaCIDD trial of cognitive impairment associated with depression, due to report resu...
2023-09-26 20:51
2168
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT
ADELAIDE, Australia and RALEIGH, N.C., Sept. 21, 2023 /PRNewswire/ -- Avance
Clinical, the award-winning Australian and North American market-leading CRO
for biotechs, announces two key appointments in the US to support its continued
global growth.
2023-09-21 19:30
2029
Körber celebrates partnership milestone with Geek+
HAMBURG, Germany, Sept. 20, 2023 /PRNewswire/ -- Global strategic partnership
empowers businesses to overcome efficiency, scalability and sustainability
challenges across supply chain
Körber
2023-09-20 18:34
2778
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...
2023-09-11 15:00
1587
World Orphan Drug Alliance Welcomes Specialised Therapeutics
* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...
2023-09-08 04:00
2283
Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet.
SYDNEY, Sept. 5, 2023 /PRNewswire/ -- Encouraging the consumption of legumes is one of the objectives of theLegumes from Europe campaign led by ANICAV – the National Association of Canned Vegetable Industries – and co-funded by the European Union to promote a healthier and more active lifestyle, ...
2023-09-05 15:00
2006
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform * ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data * ACM is in partnering d...
2023-09-05 14:00
1984
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial
Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...
2023-08-25 20:58
3198
Noodoe Links Californian and Australian Efforts to Combat Global Climate Change
With its newly opened Brisbane offices, Noodoe enables businesses from California to Australia to drive the adoption of sustainable transportation. IRVINE, Calif., Aug. 17, 2023 /PRNewswire/ -- Noodoe today announced the opening of its new offices inBrisbane, Australia as the next step in its wor...
2023-08-18 03:47
2661
THE CONQUEROR TEAMS UP WITH WARNER BROS. DISCOVERY GLOBAL CONSUMER PRODUCTS TO LAUNCH THE ULTIMATE SERIES OF VIRTUAL FITNESS CHALLENGES INSPIRED BY HBO'S GAME OF THRONES
Five Challenges, Five Medals, Following the Extraordinary Journeys of Jon Snow, Tyrion Lannister,Arya Stark, Daenerys Targaryen, and more. TAURANGA, New Zealand, Aug. 16, 2023 /PRNewswire/ -- The Conqueror Virtual Challenges, in collaboration with Warner Bros. Discovery Global Consumer Products,...
2023-08-16 14:00
2261
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis
SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...
2023-08-15 22:50
2695
HB11 Energy receives grant from US Department of Energy to develop clean, safe and unlimited fusion energy
SYDNEY, Aug. 15, 2023 /PRNewswire/ -- The U.S. Department of Energy (DoE) has
awarded a grant toHB11 Energy
2023-08-15 21:00
2273
Clarity's theranostic prostate cancer trial advances to highest dose level
Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...
2023-08-10 20:58
2805
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
Asia Pacific Defies Global Headwinds: Mastercard Economics Institute 2026 Outlook
[Picked up by 277 media titles]
2025-12-10 09:00